NO960347L - Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF - Google Patents

Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF

Info

Publication number: NO960347L
Authority: NO; Norway
Prior art keywords: tnf; treatment; pathological conditions; benzydamide; conditions caused
Prior art date: 1993-07-27

Application number

NO960347A

Other languages

English (en)

Other versions

NO960347D0 (no

NO308195B1 (no

Inventor

Valerio Cioli

Original Assignee

Angelini Francesco Ist Ricerca

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-27

Filing date

1996-01-26

Publication date

1996-03-07

1996-01-26 Application filed by Angelini Francesco Ist Ricerca filed Critical Angelini Francesco Ist Ricerca

1996-01-26 Publication of NO960347D0 publication Critical patent/NO960347D0/no

1996-03-07 Publication of NO960347L publication Critical patent/NO960347L/no

2000-08-14 Publication of NO308195B1 publication Critical patent/NO308195B1/no

Links

CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzydamine Chemical compound C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 title abstract 3
229960000333 benzydamine Drugs 0.000 title abstract 2
230000001575 pathological effect Effects 0.000 title abstract 2
239000002253 acid Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Separation Of Suspended Particles By Flocculating Agents (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO960347A 1993-07-27 1996-01-26 Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF NO308195B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT93MI001673A IT1276040B1 (it)	1993-07-27	1993-07-27	Uso della benzidamina nel trattamento di stati patologici causati dal tnf
PCT/EP1994/002343 WO1995003799A1 (en)	1993-07-27	1994-07-14	Use of benzydamine in the treatment of pathological conditions caused by tnf

Publications (3)

Publication Number	Publication Date
NO960347D0 NO960347D0 (no)	1996-01-26
NO960347L true NO960347L (no)	1996-03-07
NO308195B1 NO308195B1 (no)	2000-08-14

Family

ID=11366694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO960347A NO308195B1 (no)	1993-07-27	1996-01-26	Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF

Country Status (25)

Country	Link
US (1)	US6300358B1 (no)
EP (1)	EP0711163B1 (no)
JP (1)	JP3587851B2 (no)
CN (1)	CN1085528C (no)
AT (1)	ATE207353T1 (no)
AU (1)	AU692458B2 (no)
BG (1)	BG62841B1 (no)
CA (1)	CA2167926C (no)
CZ (1)	CZ285864B6 (no)
DE (1)	DE69428797T2 (no)
DK (1)	DK0711163T3 (no)
ES (1)	ES2163450T3 (no)
HU (1)	HU226805B1 (no)
IT (1)	IT1276040B1 (no)
LV (1)	LV11524B (no)
NO (1)	NO308195B1 (no)
NZ (1)	NZ269563A (no)
PL (1)	PL312741A1 (no)
PT (1)	PT711163E (no)
RO (1)	RO117149B1 (no)
RU (1)	RU2160102C2 (no)
SI (1)	SI0711163T1 (no)
SK (1)	SK281895B6 (no)
WO (1)	WO1995003799A1 (no)
ZA (1)	ZA945431B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2201736C1 (ru) *	2001-12-24	2003-04-10	Закрытое акционерное общество "Брынцалов-А"	Ушные капли бротинум
CN101199515B (zh) *	2007-12-21	2010-12-08	重庆市莱美药物技术有限公司	盐酸苄达明洗剂及其制备方法
MY160002A (en) *	2009-02-10	2017-02-15	Celgene Corp	Methods of using and compositions comprising pde4 modulators for treatment, prevention and management of tuberculosis
MX2012000498A (es) *	2009-07-08	2012-04-30	Acraf	Uso de bencidamina en el tratamiento de enfermedades dependientes de p40.
MD4291C1 (ro) *	2013-12-27	2015-02-28	Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова	Preparat medicamentos pentru tratamentul otitelor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1054833A (no) *	1963-08-09
US4980160A (en) *	1986-10-16	1990-12-25	Biogen, Inc.	Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases
GB8807803D0 (en) *	1988-03-31	1988-05-05	Glaxo Group Ltd	Biochemical product
IL95031A (en) *	1989-07-18	2007-03-08	Amgen Inc	Method for the production of a human recombinant tumor necrosis factor inhibitor
US5563143A (en) *	1994-09-21	1996-10-08	Pfizer Inc.	Catechol diether compounds as inhibitors of TNF release

1993
- 1993-07-27 IT IT93MI001673A patent/IT1276040B1/it active IP Right Grant
1994
- 1994-07-14 ES ES94923739T patent/ES2163450T3/es not_active Expired - Lifetime
- 1994-07-14 WO PCT/EP1994/002343 patent/WO1995003799A1/en not_active Ceased
- 1994-07-14 EP EP94923739A patent/EP0711163B1/en not_active Expired - Lifetime
- 1994-07-14 SI SI9430373T patent/SI0711163T1/xx unknown
- 1994-07-14 PT PT94923739T patent/PT711163E/pt unknown
- 1994-07-14 DE DE69428797T patent/DE69428797T2/de not_active Expired - Lifetime
- 1994-07-14 US US08/586,804 patent/US6300358B1/en not_active Expired - Lifetime
- 1994-07-14 AT AT94923739T patent/ATE207353T1/de active
- 1994-07-14 DK DK94923739T patent/DK0711163T3/da active
- 1994-07-14 CA CA002167926A patent/CA2167926C/en not_active Expired - Lifetime
- 1994-07-14 PL PL94312741A patent/PL312741A1/xx unknown
- 1994-07-14 RU RU96105062/14A patent/RU2160102C2/ru active
- 1994-07-14 HU HU9600182A patent/HU226805B1/hu unknown
- 1994-07-14 NZ NZ269563A patent/NZ269563A/en not_active IP Right Cessation
- 1994-07-14 JP JP50552795A patent/JP3587851B2/ja not_active Expired - Fee Related
- 1994-07-14 AU AU73861/94A patent/AU692458B2/en not_active Expired
- 1994-07-14 SK SK105-96A patent/SK281895B6/sk not_active IP Right Cessation
- 1994-07-14 CZ CZ96255A patent/CZ285864B6/cs not_active IP Right Cessation
- 1994-07-14 RO RO96-00144A patent/RO117149B1/ro unknown
- 1994-07-22 ZA ZA945431A patent/ZA945431B/xx unknown
1996
- 1996-01-26 NO NO960347A patent/NO308195B1/no not_active IP Right Cessation
- 1996-02-15 LV LVP-96-46A patent/LV11524B/en unknown
- 1996-02-26 BG BG100385A patent/BG62841B1/bg unknown
- 1996-07-14 CN CN94193377A patent/CN1085528C/zh not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JPH09500385A (ja)	1997-01-14
ITMI931673A1 (it)	1995-01-27
BG100385A (bg)	1996-09-30
BG62841B1 (bg)	2000-09-29
RU2160102C2 (ru)	2000-12-10
LV11524B (en)	1996-12-20
CA2167926A1 (en)	1995-02-09
US6300358B1 (en)	2001-10-09
HU226805B1 (en)	2009-10-28
PT711163E (pt)	2002-04-29
IT1276040B1 (it)	1997-10-24
NO960347D0 (no)	1996-01-26
ES2163450T3 (es)	2002-02-01
NO308195B1 (no)	2000-08-14
AU692458B2 (en)	1998-06-11
CZ285864B6 (cs)	1999-11-17
CA2167926C (en)	2004-12-21
CN1085528C (zh)	2002-05-29
AU7386194A (en)	1995-02-28
JP3587851B2 (ja)	2004-11-10
SI0711163T1 (en)	2001-12-31
LV11524A (lv)	1996-10-20
SK10596A3 (en)	1997-03-05
CN1130872A (zh)	1996-09-11
RO117149B1 (ro)	2001-11-30
NZ269563A (en)	2001-03-30
DE69428797D1 (de)	2001-11-29
ITMI931673A0 (it)	1993-07-27
EP0711163B1 (en)	2001-10-24
PL312741A1 (en)	1996-05-13
DK0711163T3 (da)	2001-11-26
HUT73500A (en)	1996-08-28
SK281895B6 (sk)	2001-09-11
DE69428797T2 (de)	2002-04-18
WO1995003799A1 (en)	1995-02-09
ZA945431B (en)	1995-02-28
EP0711163A1 (en)	1996-05-15
CZ25596A3 (en)	1996-07-17
ATE207353T1 (de)	2001-11-15

Similar Documents

Publication	Publication Date	Title
TR199801180T2 (xx)	1998-10-21	Aneljestik etkiye sahip yeni bile�ikler.
CA2274074A1 (en)	1998-07-02	Novel compounds with analgesic effect
EP1029540A3 (en)	2001-05-16	Use of droloxifene for the treatment of cardiovascular diseases
CA2289717A1 (en)	1998-11-12	Novel therapy for constipation
IE780643L (en)	1978-10-29	THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES
DE69331605D1 (de)	2002-03-28	Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE69814394D1 (de)	2003-06-12	Verwendung von levobupivacain
ATE99172T1 (de)	1994-01-15	Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
RU94002133A (ru)	1995-10-27	6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство
ES2026304A6 (es)	1992-04-16	Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
TR200000455T2 (tr)	2000-09-21	Alzheimer hastalığının tedavisinde fankinonun kullanılması.
HK1046089A1 (zh)	2002-12-27	褪黑激素的治疗用途
NO960347D0 (no)	1996-01-26	Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
HUP9902135A2 (hu)	1999-11-29	(+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
TR199801184T2 (xx)	1998-09-21	Analjezik tesirli yeni bile�ikler.
NZ303993A (en)	2000-12-22	Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
RU94011321A (ru)	1996-01-20	Способ профилактики и лечения заболеваний кожи
ZA885590B (en)	1990-03-28	Pharmaceutical composition intended for the prevention and treatment of bacterial or viral diseases
DE69100171D1 (de)	1993-08-19	Synergistische kombination zur ophthalmischen verwendung.
WO1986006960A3 (en)	1987-01-29	Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
CA2135752A1 (en)	1993-12-09	Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease
FI953725A0 (fi)	1995-08-04	Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi
RU95115500A (ru)	1997-09-10	Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическими и дегенератными изменениями органов и тканей
DE69228235D1 (de)	1999-03-04	Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung
CA2341891A1 (en)	2000-03-09	The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders

Legal Events

Date	Code	Title	Description
2014-07-21	MK1K	Patent expired